These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15350898)

  • 1. Cdk5 deregulation in the pathogenesis of Alzheimer's disease.
    Cruz JC; Tsai LH
    Trends Mol Med; 2004 Sep; 10(9):452-8. PubMed ID: 15350898
    [No Abstract]   [Full Text] [Related]  

  • 2. Cdk5, a therapeutic target for Alzheimer's disease?
    Tsai LH; Lee MS; Cruz J
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):137-42. PubMed ID: 15023356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Tau with Fe65 links tau to APP.
    Barbato C; Canu N; Zambrano N; Serafino A; Minopoli G; Ciotti MT; Amadoro G; Russo T; Calissano P
    Neurobiol Dis; 2005 Mar; 18(2):399-408. PubMed ID: 15686969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
    Ubeda M; Kemp DM; Habener JF
    Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When good Cdk5 turns bad.
    Guo Q
    Sci Aging Knowledge Environ; 2006 Feb; 2006(5):pe5. PubMed ID: 16469730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.
    Iijima K; Ando K; Takeda S; Satoh Y; Seki T; Itohara S; Greengard P; Kirino Y; Nairn AC; Suzuki T
    J Neurochem; 2000 Sep; 75(3):1085-91. PubMed ID: 10936190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of Cdk5 activity in post-mitotic neurons].
    Saito T; Hisanaga S
    Seikagaku; 2001 Apr; 73(4):276-8. PubMed ID: 11449683
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease. The tangled tale of tau.
    Mandelkow E
    Nature; 1999 Dec; 402(6762):588-9. PubMed ID: 10604460
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversies over p25 in Alzheimer's disease.
    Nguyen KC; Rosales JL; Barboza M; Lee KY
    J Alzheimers Dis; 2002 Apr; 4(2):123-6. PubMed ID: 12214136
    [No Abstract]   [Full Text] [Related]  

  • 11. Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells.
    Strocchi P; Pession A; Dozza B
    J Cell Biochem; 2003 Mar; 88(4):758-65. PubMed ID: 12577309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: a dissection of its etiology.
    Jay G
    J Neurovirol; 1997 May; 3 Suppl 1():S41-2. PubMed ID: 9179790
    [No Abstract]   [Full Text] [Related]  

  • 13. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
    Kesavapany S; Lau KF; McLoughlin DM; Brownlees J; Ackerley S; Leigh PN; Shaw CE; Miller CC
    Eur J Neurosci; 2001 Jan; 13(2):241-7. PubMed ID: 11168528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11alpha protein up-regulation in Alzheimer's disease.
    Jacobs EH; Williams RJ; Francis PT
    Neuroscience; 2006; 138(2):511-22. PubMed ID: 16413130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
    Alvarez A; Muñoz JP; Maccioni RB
    Exp Cell Res; 2001 Apr; 264(2):266-74. PubMed ID: 11262183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the Cdk5--p35 kinase in neuronal development.
    Paglini G; Cáceres A
    Eur J Biochem; 2001 Mar; 268(6):1528-33. PubMed ID: 11248669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain.
    Swatton JE; Sellers LA; Faull RL; Holland A; Iritani S; Bahn S
    Eur J Neurosci; 2004 May; 19(10):2711-9. PubMed ID: 15147305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
    J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.